Splenomegaly was reported in 62% of patients and lymphadenopathy in 33%. Immunologically, ANA positivity was near-universal, with anti-DNA present in 81.8% of cases and anti-Ro, anti-Sm, and anti-RNP ...

The analysis covers Cold Agglutinin market uptake by drugs, patient uptake by therapies, and sales of each drug. Moreover, the therapeutics assessment section helps understand the drugs with the ...

The direct antiglobulin test was positive for anti-C3d specificity, with cold agglutinin titer confirming the diagnosis of CAD.

Enjaymo, a humanized monoclonal antibody, helps treat Cold Agglutinin Disease by reducing the risk of hemolysis in patients. • Key drugs in development for CAD include LNP023 (iptacopan), INCB050465 ...

The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends. Cold Agglutinin Disease Drugs Uptake and Pipeline Development Activities The drugs ...

Sanofi has won FDA approval for its sutimlimab for cold agglutinin disease (CAD ... cleared decrease the need for blood transfusions in patients with CAD, an autoimmune disease which results ...

Cold agglutinins produced in the setting of B cell neoplasms, such as lymphoplasmacytic lymphoma and plasma cell myeloma, can mediate autoimmune haemolytic anemia. Transfusion of these patients can ...

DelveInsight's Cold Agglutinin Disease Market Report provides comprehensive insights into the epidemiology and market dynamics across the 7MM. LAS VEGAS , NV, UNITED STATES, January 23, 2025 /EIN ...

5. Blood Disorders Certain blood disorders can lead to Raynaud's symptoms and other effects. A rare anemia called cold agglutinin disease is among them; it has been associated with chronic lymphocytic ...